Literature DB >> 17617073

Antiarrhythmic induced electrical storm in Brugada syndrome: a case report.

Sandeep Joshi1, Farbod Raiszadeh, Walter Pierce, Jonathan S Steinberg.   

Abstract

Brugada syndrome (BS) may be "unmasked" by several pharmacological and/or physiological agents in an otherwise normal electrocardiogram. Once diagnosed the possibility of persistent ventricular tachycardia/fibrillation exists. Although this is treated with various antiarrhythmic agents, there remains a cohort of patients who fail to respond to conventional antiarrhythmic therapy therefore, amplifying the electrical storm. We report a case of a BS diagnosed via procainamide challenge, the resultant near fatal electrical storm aggravated by amiodarone and the eventual resolution with isoproterenol.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17617073      PMCID： PMC6932674          DOI： 10.1111/j.1542-474X.2007.00171.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN： 1082-720X            Impact factor:   1.468


  22 in total

Review 1.  Brugada syndrome: 1992-2002: a historical perspective.

Authors:  Charles Antzelevitch; Pedro Brugada; Josep Brugada; Ramon Brugada; Jeffrey A Towbin; Kolawanee Nademanee
Journal:  J Am Coll Cardiol       Date:  2003-05-21       Impact factor: 24.094

Review 2.  The Brugada syndrome: is an implantable cardioverter defibrillator the only therapeutic option?

Authors:  Bernard Belhassen; Sami Viskin; Charles Antzelevitch
Journal:  Pacing Clin Electrophysiol       Date:  2002-11       Impact factor: 1.976

3.  Flecainide test in Brugada syndrome: a reproducible but risky tool.

Authors:  Maurizio Gasparini; Silvia G Priori; Massimo Mantica; Carlo Napolitano; Paola Galimberti; Carlo Ceriotti; Stefano Simonini
Journal:  Pacing Clin Electrophysiol       Date:  2003-01       Impact factor: 1.976

4.  Right bundle-branch block and ST-segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease.

Authors:  J Brugada; R Brugada; P Brugada
Journal:  Circulation       Date:  1998-02-10       Impact factor: 29.690

Review 5.  Brugada syndrome: report of the second consensus conference.

Authors:  Charles Antzelevitch; Pedro Brugada; Martin Borggrefe; Josep Brugada; Ramon Brugada; Domenico Corrado; Ihor Gussak; Herve LeMarec; Koonlawee Nademanee; Andres Ricardo Perez Riera; Wataru Shimizu; Eric Schulze-Bahr; Hanno Tan; Arthur Wilde
Journal:  Heart Rhythm       Date:  2005-04       Impact factor: 6.343

6.  Tricyclic antidepressants and the Brugada syndrome: an example of Brugada waves appearing after the administration of desipramine.

Authors:  Vasilis C Babaliaros; J Willis Hurst
Journal:  Clin Cardiol       Date:  2002-08       Impact factor: 2.882

7.  Natural history of Brugada syndrome: the prognostic value of programmed electrical stimulation of the heart.

Authors:  Pedro Brugada; Ramon Brugada; Lluis Mont; Maximo Rivero; Peter Geelen; Josep Brugada
Journal:  J Cardiovasc Electrophysiol       Date:  2003-05

8.  Electrical storm in patients with transvenous implantable cardioverter-defibrillators: incidence, management and prognostic implications.

Authors:  S C Credner; T Klingenheben; O Mauss; C Sticherling; S H Hohnloser
Journal:  J Am Coll Cardiol       Date:  1998-12       Impact factor: 24.094

9.  Ventricular arrhythmia induced by sodium channel blocker in patients with Brugada syndrome.

Authors:  Hiroshi Morita; Shiho Takenaka Morita; Satoshi Nagase; Kimikazu Banba; Nobuhiro Nishii; Yoshinori Tani; Atsuyuki Watanabe; Kazufumi Nakamura; Kengo Fukushima Kusano; Tetsuro Emori; Hiromi Matsubara; Kazumasa Hina; Toshimasa Kita; Tohru Ohe
Journal:  J Am Coll Cardiol       Date:  2003-11-05       Impact factor: 24.094

Review 10.  Catecholaminergic polymorphic ventricular tachycardia.

Authors:  Johnson Francis; Vikram Sankar; Venugopal Krishnan Nair; Silvia G Priori
Journal:  Heart Rhythm       Date:  2005-05       Impact factor: 6.343
View more
  5 in total

1.  Successful acute and long-term management of electrical storm in Brugada syndrome using orciprenaline and quinine/quinidine.

Authors:  Patrick A Schweizer; Rüdiger Becker; Hugo A Katus; Dierk Thomas
Journal:  Clin Res Cardiol       Date:  2010-03-11       Impact factor: 5.460

Review 2.  Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org).

Authors:  Pieter G Postema; Christian Wolpert; Ahmad S Amin; Vincent Probst; Martin Borggrefe; Dan M Roden; Silvia G Priori; Hanno L Tan; Masayasu Hiraoka; Josep Brugada; Arthur A M Wilde
Journal:  Heart Rhythm       Date:  2009-07-08       Impact factor: 6.343

3.  Prevalence of supraventricular tachyarrhythmias in a cohort of 115 patients with Brugada syndrome.

Authors:  Rainer Schimpf; Carla Giustetto; Lars Eckardt; Christian Veltmann; Christian Wolpert; Fiorenzo Gaita; Günter Breithardt; Martin Borggrefe
Journal:  Ann Noninvasive Electrocardiol       Date:  2008-07       Impact factor: 1.468

Review 4.  Pharmacological Therapy in Brugada Syndrome.

Authors:  Oholi Tovia Brodie; Yoav Michowitz; Bernard Belhassen
Journal:  Arrhythm Electrophysiol Rev       Date:  2018-06

Review 5.  Role of Provocable Brugada ECG Pattern in The Correct Risk Stratification for Major Arrhythmic Events.

Authors:  Nicolò Martini; Martina Testolina; Gian Luca Toffanin; Rocco Arancio; Luca De Mattia; Sergio Cannas; Giovanni Morani; Bortolo Martini
Journal:  J Clin Med       Date:  2021-03-02       Impact factor: 4.241
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.